abstract depression and ptsd are treated by administration of hcg, or an hcg analog, or a prodrug or metabolite of hcg or an hcg analog, in an amount equivalent to a subcutaneous dose of 50 - 200 iu, preferably 120 - 170 iu, more preferably 140 - 160 iu, of hcg per day. abstract of patent summary: "treatment of depression and ptsd". Depression and ptsd are treated by administration of hcg, or an hcg analog, or a prodrug or metabolite of hcg, in an amount equivalent to a subcutaneous dose of 50-200 iu, preferably 120-170 iu, more preferably 140 -160 iu, hcg per day.abstract depression and ptsd are treated by administration of hcg, or an hcg analog, or a prodrug or metabolite of hcg or an hcg analog, in an amount equivalent to a subcutaneous dose of 50 - 200 iu, preferably 120 - 170 iu, more preferably 140 - 160 iu, of hcg per day. tradução do resumo resumo patente de invenção: "tratamento de depressão e ptsd". depressão e ptsd são tratados através de administração de hcg, ou um análogo de hcg, ou uma pró-droga ou metabólito de hcg, em uma quantidade equivalente a uma dose subcutânea de 50-200 iu, preferivelmente 120-170 iu, mais preferivelmente 140-160 iu, de hcg por dia.
